InvestorsHub Logo
Followers 16
Posts 1062
Boards Moderated 0
Alias Born 09/01/2019

Re: None

Wednesday, 02/24/2021 6:24:06 PM

Wednesday, February 24, 2021 6:24:06 PM

Post# of 16703
AGN may work with Charles River Labs. The short Cramer clip talks about portions of the market they are involved in. Pretty good work by AGN CEO to get a foot in that door and a path set.

I posted the Rem results because it included how many sites just Rem would control. Times many from other big Pharma. It was sharp work to fill and complete the COVID Trial. IMO.
In the results (I) saw High P values and high adverse effects? Maybe someone qualified can relate their results to AGN expected results.

The inclusion of supplemental info and x-rays may support the decisions of primary and secondary outcomes for the now DSMB approved Phase 3 Trial. Adding ARDS and CC etc may be possible. A Covid after effect is lung damage. Maybe dosage thru longer lengths. I think CM has thought of many things.